Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma.

Lara, P C; Garcia-Puche, J L; Pedraza, V

Lara, P C; Garcia-Puche, J L; Pedraza, V.

Affiliation

Lara PC; Department of Radiotherapy and Oncology, University Hospital, Granada, Spain.

Cancer Chemother Pharmacol ; 26 Suppl: S36-8, 1990.

Article in En | MEDLINE | ID: mdl-2347047

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Squamous Cell/drug therapy; Cisplatin/administration & dosage; Ifosfamide/administration & dosage; Uterine Cervical Neoplasms/drug therapy; Adult; Aged; Cisplatin/adverse effects; Female; Humans; Ifosfamide/adverse effects; Middle Aged; Neoplasm Staging

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Uterine Cervical Neoplasms / Cisplatin / Ifosfamide Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 1990 Document type: Article Affiliation country: Spain Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links